IKBKB and Miyoshi myopathy: In order to study the effect of the combination of the IKK2 inhibitor AS602868 and the anti- IGF-1R monoclonal antibody on four human MM cell lines, we incubated cells with various concentrations of AS602868 alone or in combination with 10 μg/mL anti-IGF-1R.